| |
| |
| Exchange: |
American Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
10,590,000 |
| Market
Cap: |
3.18(K) |
| Last
Volume: |
13,822,625 |
Avg
Vol: |
11,146,411 |
| 52
Week Range: |
$0.0002 - $0.055675 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Appliances & Equipment |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Viveve Medical is a holding company. Through its subsidiaries, Co. designs, develops, manufactures and markets a platform medical technology, which it refers to as Cryogen-cooled Monopolar Radiofrequency (CMRF). Co.'s proprietary CMRF technology is delivered through a radiofrequency generator, handpiece and treatment tip, that collectively, Co. refers to as the Viveve® System. The Viveve System is for the non-invasive treatment of vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence depending on the relevant country-specific clearance or approval, that Co. refers to as the Viveve treatment.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-08 |
2023-11-07 |
2023-05-09 |
2022-05-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Durbin Scott |
Chief Financial Officer |
• • – |
2015-05-12 |
4 |
B |
$0.37 |
$15,000 |
D/D |
40,541 |
40,541 |
2.74 |
- |
|
| Gbs Bioventures Iii A/c |
10% Owner |
– – • |
2014-09-23 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,650,935 |
|
- |
|
| Gbs Bioventures Iii A/c |
10% Owner |
– – • |
2014-09-23 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,650,935 |
|
- |
|
| Gbs Bioventures Iii A/c |
10% Owner |
• • • |
2014-09-23 |
4 |
B |
$0.53 |
$502,372 |
D/D |
947,872 |
3,598,807 |
2.45 |
- |
|
| Gbs Bioventures Iii A/c |
10% Owner |
• • • |
2014-09-23 |
4 |
B |
$0.53 |
$502,372 |
I/I |
947,872 |
3,598,807 |
1.5 |
- |
|
| Smith Brigitte |
Director |
– • • |
2014-09-23 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,650,935 |
|
- |
|
| Smith Brigitte |
Director |
• • • |
2014-09-23 |
4 |
B |
$0.53 |
$101,899 |
D/D |
192,262 |
3,791,069 |
3.92 |
- |
|
| Smith Brigitte |
Director |
• • • |
2014-09-23 |
4 |
B |
$0.53 |
$502,372 |
I/I |
947,872 |
3,598,807 |
2.25 |
- |
|
| Alta Bioequities, L.p. |
Director |
– • • |
2014-09-23 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,895,788 |
|
- |
|
| Simpson Carl |
Director |
– • – |
2014-09-23 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
15,384 |
|
- |
|
| Janney Daniel |
Director |
• • • |
2014-09-23 |
4 |
B |
$0.53 |
$1,004,768 |
I/I |
1,895,788 |
1,895,788 |
2.64 |
- |
|
| Diekman John D |
10% Owner |
– – • |
2014-09-23 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,707,339 |
|
- |
|
| Diekman John D |
10% Owner |
– – • |
2014-09-23 |
4 |
B |
$0.53 |
$2,764,302 |
I/I |
5,215,664 |
262,798 |
1.5 |
- |
|
| Colella Mark Samuel |
Director |
– • • |
2014-09-23 |
4 |
B |
$0.53 |
$2,764,302 |
I/I |
5,215,664 |
262,798 |
2.25 |
- |
|
| Colella Mark Samuel |
Director |
– • • |
2014-09-23 |
4 |
A |
$0.00 |
$0 |
I/I |
1,707,339 |
64,811 |
|
- |
|
| Kayne Fred |
Shareholder |
– – – |
2008-12-17 |
4 |
S |
$0.05 |
$83,500 |
D/D |
(1,670,000) |
1,063,300 |
|
- |
|
| Holmes Benjamin L |
Director |
– • – |
2008-12-11 |
4 |
B |
$0.05 |
$1,000 |
D/D |
20,000 |
50,000 |
2.31 |
- |
|
| Tauscher Mark R |
President & CEO |
• • – |
2008-12-11 |
4 |
B |
$0.04 |
$1,491 |
D/D |
32,000 |
259,068 |
2.73 |
- |
|
| Tauscher Mark R |
President & CEO |
• • – |
2008-12-10 |
4 |
B |
$0.04 |
$1,210 |
D/D |
29,500 |
227,068 |
2.73 |
- |
|
| Holmes Benjamin L |
Director |
– • – |
2008-12-10 |
4 |
B |
$0.04 |
$700 |
D/D |
20,000 |
30,000 |
2.31 |
- |
|
| Tauscher Mark R |
President & CEO |
• • – |
2008-12-09 |
4 |
B |
$0.04 |
$175 |
D/D |
5,000 |
197,568 |
2.73 |
- |
|
| Kayne Fred |
Shareholder |
– – – |
2008-12-09 |
4 |
S |
$0.36 |
$122,940 |
D/D |
(341,500) |
2,733,300 |
|
- |
|
| Tauscher Mark R |
President & CEO |
• • – |
2008-12-08 |
4 |
B |
$0.04 |
$140 |
D/D |
4,000 |
192,568 |
2.73 |
- |
|
| Tauscher Mark R |
President & CEO |
• • – |
2008-12-05 |
4 |
B |
$0.04 |
$800 |
D/D |
20,000 |
188,568 |
2.73 |
- |
|
| Tauscher Mark R |
President & CEO |
• • – |
2008-12-04 |
4 |
B |
$0.04 |
$800 |
D/D |
20,000 |
168,568 |
2.73 |
- |
|
165 Records found
|
|
Page 6 of 7 |
|
|
